Key statistics
As of last trade PTC Therapeutics Inc (BH3:DEU) traded at 32.60, -14.66% below its 52-week high of 38.20, set on May 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 31.60 |
---|---|
High | 33.00 |
Low | 31.60 |
Bid | 32.40 |
Offer | 33.20 |
Previous close | 32.00 |
Average volume | 14.29 |
---|---|
Shares outstanding | 76.92m |
Free float | 75.12m |
P/E (TTM) | -- |
Market cap | 2.82bn USD |
EPS (TTM) | -6.32 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Press releases
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PTC Therapeutics to Participate at Upcoming Investor Conferences
- PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
- PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
- PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
- CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review
More ▼